Investigation of the changes in the presynaptic inhibition in association with the subthalamic nucleus stimulation in Parkinson's disease.

H-reflex Parkinson's disease Presynaptic inhibition pathophysiology subthalamic nucleus deep brain stimulation

Journal

Neurological research
ISSN: 1743-1328
Titre abrégé: Neurol Res
Pays: England
ID NLM: 7905298

Informations de publication

Date de publication:
Nov 2022
Historique:
pubmed: 7 6 2022
medline: 4 11 2022
entrez: 6 6 2022
Statut: ppublish

Résumé

Presynaptic inhibition (PSI) is a critical spinal inhibitory mechanism for modulating muscle coordination by adjusting both supraspinal motor commands and sensory feedback at the spinal level. The literature data regarding the role of PSI in the efficiency of STN-DBS therapy in Parkinson's disease (PD) are limited. We aimed to investigate the possible alteration in this pathway in association with the STN stimulation (STIM) within the very early period after the STIM is off. We performed the H-reflex investigation on 8 PD subjects with STN-DBS who applied to our polyclinic for routine clinical evaluations. The investigations were initially performed at the STIM-on period and repeated after the STIM set is off for 5 min. A The results of the analyses did not reveal marked changes in the variables of the H-reflex between the STIM-on and -off states. PSI do not alter in the very early period after the STIM is off. Taken together with the related literature data and our study results, it can be hypothesized that the PSI might involve in the DBS efficiency in the later phase of the STIM as a compensatory mechanism. Further prospective studies including a larger number of patients with serial electrophysiological recordings to investigate the temporal course of the underlying dynamics are required to clarify these discussions.

Sections du résumé

BACKGROUND AND PURPOSE UNASSIGNED
Presynaptic inhibition (PSI) is a critical spinal inhibitory mechanism for modulating muscle coordination by adjusting both supraspinal motor commands and sensory feedback at the spinal level. The literature data regarding the role of PSI in the efficiency of STN-DBS therapy in Parkinson's disease (PD) are limited. We aimed to investigate the possible alteration in this pathway in association with the STN stimulation (STIM) within the very early period after the STIM is off.
METHODS UNASSIGNED
We performed the H-reflex investigation on 8 PD subjects with STN-DBS who applied to our polyclinic for routine clinical evaluations. The investigations were initially performed at the STIM-on period and repeated after the STIM set is off for 5 min. A
RESULTS UNASSIGNED
The results of the analyses did not reveal marked changes in the variables of the H-reflex between the STIM-on and -off states.
CONCLUSION UNASSIGNED
PSI do not alter in the very early period after the STIM is off. Taken together with the related literature data and our study results, it can be hypothesized that the PSI might involve in the DBS efficiency in the later phase of the STIM as a compensatory mechanism. Further prospective studies including a larger number of patients with serial electrophysiological recordings to investigate the temporal course of the underlying dynamics are required to clarify these discussions.

Identifiants

pubmed: 35658895
doi: 10.1080/01616412.2022.2084812
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

969-974

Auteurs

Halil Onder (H)

Neurology Clinic, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.

Bektas Korkmaz (B)

Neurology Clinic, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.

Bilge Gonenli Kocer (BG)

Neurology Clinic, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.

Selcuk Comoglu (S)

Neurology Clinic, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH